Literature DB >> 1978916

Proteinuria as complication of simvastatin treatment.

J P Deslypere, J Delanghe, A Vermeulen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1978916     DOI： 10.1016/0140-6736(90)93164-k

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.

Authors:  E Hommel; P Andersen; M A Gall; F Nielsen; B Jensen; P Rossing; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 2.  Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

Authors:  Roberto Scarpioni; Marco Ricardi; Vittorio Albertazzi; Luigi Melfa
Journal:  World J Nephrol       Date:  2012-12-06

3.  Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network.

Authors:  Christopher G Rowan; Steven M Brunelli; Jeffrey Munson; James Flory; Peter P Reese; Sean Hennessy; James Lewis; Daniel Mines; Jeffrey S Barrett; Warren Bilker; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-03-16       Impact factor: 2.890

4.  One year experience in the treatment of familial hypercholesterolaemia with simvastatin.

Authors:  J Quiney; G F Watts; M Kerr-Muir; B Slavin; B Lewis
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study.

Authors:  Arjan van der Tol; Wim Van Biesen; Steven Van Laecke; Kris Bogaerts; Koen De Lombaert; Hans Warrinnier; Raymond Vanholder
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study.

Authors:  Young-Gun Kim; JungHyun Byun; Dukyong Yoon; Ja Young Jeon; Seung Jin Han; Dae Jung Kim; Kwan-Woo Lee; Rae Woong Park; Hae Jin Kim
Journal:  J Diabetes Res       Date:  2016-12-29       Impact factor: 4.011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.